Gene · 7804
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| tRFs and tRNA Halves: Novel Cellular Defenders in Multiple Biological Processes. | Curr Issues Mol Biol | 2022 | 36547066 | PubTator, text mining | PubMed |
| Macromolecules Absorbed from Influenza Infection-Based Sera Modulate the Cellular Uptake of Polymeric Nanoparticles. | Biomimetics (Basel) | 2022 | 36546919 | PubTator, text mining | PubMed |
| Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. | Front Immunol | 2022 | 36544755 | PubTator, text mining | PubMed |
| Distinct non-coding RNA cargo of extracellular vesicles from M1 and M2 human primary macrophages. | J Extracell Vesicles | 2022 | 36544271 | PubTator, text mining | PubMed |
| Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. | Front Immunol | 2022 | 36524125 | PubTator, text mining | PubMed |
| Effect of e-cigarette aerosol on gingival mucosa structure and proinflammatory cytokine response. | Toxicol Rep | 2022 | 36518404 | PubTator, text mining | PubMed |
| PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia. | Sci Adv | 2022 | 36516256 | PubTator, text mining | PubMed |
| Apolipoproteins: New players in cancers. | Front Pharmacol | 2022 | 36506554 | PubTator, text mining | PubMed |
| Brain Region-Dependent Alternative Splicing of Alzheimer Disease (AD)-Risk Genes Is Associated With Neuropathological Features in AD. | Int Neurourol J | 2022 | 36503215 | PubTator, text mining | PubMed |
| Selenium in Bodily Homeostasis: Hypothalamus, Hormones, and Highways of Communication. | Int J Mol Sci | 2022 | 36499772 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Intercellular communication analysis of the human retinal pigment epithelial and choroidal cells predicts pathways associated with aging, cellular senescence and age-related macular degeneration. | Front Aging Neurosci | 2022 | 36408112 | PubTator, text mining | PubMed |
| Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention. | Medicine (Baltimore) | 2022 | 36397406 | PubTator, text mining | PubMed |
| Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers. | Biomolecules | 2022 | 36358931 | PubTator, text mining | PubMed |
| MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer. | BMC Cancer | 2022 | 36357836 | PubTator, text mining | PubMed |
| Tumor Apolipoprotein E is a key checkpoint blocking anti-tumor immunity in mouse melanoma. | Front Immunol | 2022 | 36341364 | PubTator, text mining | PubMed |
| The role of human ribonuclease A family in health and diseases: A systematic review. | iScience | 2022 | 36304117 | PubTator, text mining | PubMed |
| PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease. | Int J Mol Sci | 2022 | 36293049 | PubTator, text mining | PubMed |
| Reelin Protects against Colon Pathology via p53 and May Be a Biomarker for Colon Cancer Progression. | Biology (Basel) | 2022 | 36290310 | PubTator, text mining | PubMed |
| Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma. | J Exp Clin Cancer Res | 2022 | 36273157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7804/papers?page=15